
Po-chih Chen
Examiner (ID: 15962, Phone: (571)270-7243 , Office: P/1626 )
| Most Active Art Unit | 1626 |
| Art Unit(s) | 1621, 1626 |
| Total Applications | 947 |
| Issued Applications | 619 |
| Pending Applications | 116 |
| Abandoned Applications | 237 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19948337
[patent_doc_number] => 12319684
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-06-03
[patent_title] => Agonists of the apelin receptor and methods of use thereof
[patent_app_type] => utility
[patent_app_number] => 17/208919
[patent_app_country] => US
[patent_app_date] => 2021-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18784
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17208919
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/208919 | Agonists of the apelin receptor and methods of use thereof | Mar 21, 2021 | Issued |
Array
(
[id] => 18375953
[patent_doc_number] => 20230151034
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-18
[patent_title] => PEPTIDOMIMETIC N5-METHYL-N2-(NONANOYL-L-LEUCYL)-L-GLUTAMINATE DERIVATIVES, TRIAZASPIRO[4.14]NONADECANE DERIVATIVES AND SIMILAR COMPOUNDS AS INHIBITORS OF NOROVIRUS AND CORONAVIRUS REPLICATION
[patent_app_type] => utility
[patent_app_number] => 17/911461
[patent_app_country] => US
[patent_app_date] => 2021-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 68528
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -103
[patent_words_short_claim] => 4
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17911461
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/911461 | PEPTIDOMIMETIC N5-METHYL-N2-(NONANOYL-L-LEUCYL)-L-GLUTAMINATE DERIVATIVES, TRIAZASPIRO[4.14]NONADECANE DERIVATIVES AND SIMILAR COMPOUNDS AS INHIBITORS OF NOROVIRUS AND CORONAVIRUS REPLICATION | Mar 16, 2021 | Pending |
Array
(
[id] => 18995847
[patent_doc_number] => 11912674
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-02-27
[patent_title] => Isoxazole derivatives as nuclear receptor agonists and uses thereof
[patent_app_type] => utility
[patent_app_number] => 17/191806
[patent_app_country] => US
[patent_app_date] => 2021-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36255
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17191806
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/191806 | Isoxazole derivatives as nuclear receptor agonists and uses thereof | Mar 3, 2021 | Issued |
Array
(
[id] => 17096831
[patent_doc_number] => 20210284622
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-16
[patent_title] => BIOACTIVE POLYMERS WITH ANTI=FOULING PROPERTIES FOR MEDICAL AND DENTAL USES
[patent_app_type] => utility
[patent_app_number] => 17/191552
[patent_app_country] => US
[patent_app_date] => 2021-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3309
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 444
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17191552
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/191552 | BIOACTIVE POLYMERS WITH ANTI=FOULING PROPERTIES FOR MEDICAL AND DENTAL USES | Mar 2, 2021 | Abandoned |
Array
(
[id] => 17080575
[patent_doc_number] => 20210275581
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-09
[patent_title] => Oral Care Composition Containing Cetylpyridinium Tetrachlorozincate
[patent_app_type] => utility
[patent_app_number] => 17/249489
[patent_app_country] => US
[patent_app_date] => 2021-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11201
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17249489
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/249489 | Oral Care Composition Containing Cetylpyridinium Tetrachlorozincate | Mar 2, 2021 | Abandoned |
Array
(
[id] => 16900676
[patent_doc_number] => 20210179592
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-17
[patent_title] => 3-((HETERO-)ARYL)-ALKYL-8-AMINO-2-OXO-1,3-DIAZA-SPIRO-[4.5]-DECANE DERIVATIVES
[patent_app_type] => utility
[patent_app_number] => 17/188743
[patent_app_country] => US
[patent_app_date] => 2021-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30635
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 1035
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17188743
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/188743 | 3-((HETERO-)ARYL)-ALKYL-8-AMINO-2-OXO-1,3-DIAZA-SPIRO-[4.5]-DECANE DERIVATIVES | Feb 28, 2021 | Abandoned |
Array
(
[id] => 16977558
[patent_doc_number] => 20210221795
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-22
[patent_title] => AMORPHOUS FORMS OF SELINEXOR AND PROCESS FOR THEIR PREPARATION
[patent_app_type] => utility
[patent_app_number] => 17/188625
[patent_app_country] => US
[patent_app_date] => 2021-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20779
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17188625
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/188625 | AMORPHOUS FORMS OF SELINEXOR AND PROCESS FOR THEIR PREPARATION | Feb 28, 2021 | Abandoned |
Array
(
[id] => 16900679
[patent_doc_number] => 20210179595
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-17
[patent_title] => 8-Amino-2-Oxo-1,3-Diaza-Spiro-[4.5]-Decane Derivatives
[patent_app_type] => utility
[patent_app_number] => 17/188706
[patent_app_country] => US
[patent_app_date] => 2021-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32765
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -30
[patent_words_short_claim] => 1069
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17188706
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/188706 | 8-Amino-2-Oxo-1,3-Diaza-Spiro-[4.5]-Decane Derivatives | Feb 28, 2021 | Abandoned |
Array
(
[id] => 16915768
[patent_doc_number] => 20210188860
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-24
[patent_title] => 3-((Hetero-)Aryl)-8-Amino-2-Oxo-1,3-Diaza-Spiro-[4.5]-Decane Derivatives
[patent_app_type] => utility
[patent_app_number] => 17/188860
[patent_app_country] => US
[patent_app_date] => 2021-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 46836
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 1065
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17188860
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/188860 | 3-((Hetero-)Aryl)-8-Amino-2-Oxo-1,3-Diaza-Spiro-[4.5]-Decane Derivatives | Feb 28, 2021 | Abandoned |
Array
(
[id] => 16900711
[patent_doc_number] => 20210179627
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-17
[patent_title] => 3-(Carboxymethyl)-8-Amino-2-Oxo-1,3-Diaza-Spiro-[4.5]-Decane Derivatives
[patent_app_type] => utility
[patent_app_number] => 17/188884
[patent_app_country] => US
[patent_app_date] => 2021-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32894
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -31
[patent_words_short_claim] => 1295
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17188884
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/188884 | 3-(Carboxymethyl)-8-Amino-2-Oxo-1,3-Diaza-Spiro-[4.5]-Decane Derivatives | Feb 28, 2021 | Abandoned |
Array
(
[id] => 16962816
[patent_doc_number] => 20210214315
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-15
[patent_title] => 3-((Hetero-)Aryl)-8-Amino-2-Oxo-1,3-Diaza-Spiro-[4.5]-Decane Derivatives
[patent_app_type] => utility
[patent_app_number] => 17/188802
[patent_app_country] => US
[patent_app_date] => 2021-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26459
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -33
[patent_words_short_claim] => 1339
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17188802
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/188802 | 3-((Hetero-)Aryl)-8-Amino-2-Oxo-1,3-Diaza-Spiro-[4.5]-Decane Derivatives | Feb 28, 2021 | Abandoned |
Array
(
[id] => 20663605
[patent_doc_number] => 12605354
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-04-21
[patent_title] => Azelaic acid esters in the treatment or prevention of dyslipidemia and associated conditions
[patent_app_type] => utility
[patent_app_number] => 17/179935
[patent_app_country] => US
[patent_app_date] => 2021-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 29
[patent_no_of_words] => 13676
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17179935
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/179935 | Azelaic acid esters in the treatment or prevention of dyslipidemia and associated conditions | Feb 18, 2021 | Issued |
Array
(
[id] => 19638561
[patent_doc_number] => 12169166
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-12-17
[patent_title] => Fluorogenic cyanine compounds for detecting nucleic acids
[patent_app_type] => utility
[patent_app_number] => 17/176847
[patent_app_country] => US
[patent_app_date] => 2021-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 12
[patent_no_of_words] => 16056
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17176847
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/176847 | Fluorogenic cyanine compounds for detecting nucleic acids | Feb 15, 2021 | Issued |
Array
(
[id] => 18478262
[patent_doc_number] => 11691992
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-07-04
[patent_title] => Oxaborole analogs and uses thereof
[patent_app_type] => utility
[patent_app_number] => 17/173884
[patent_app_country] => US
[patent_app_date] => 2021-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 4
[patent_no_of_words] => 28421
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 98
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17173884
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/173884 | Oxaborole analogs and uses thereof | Feb 10, 2021 | Issued |
Array
(
[id] => 18272234
[patent_doc_number] => 20230093476
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-23
[patent_title] => SUBSTITUTED FUSED IMIDAZOLE DERIVATIVES AND METHODS OF TREATING REFRACTIVE OCULAR DISORDERS
[patent_app_type] => utility
[patent_app_number] => 17/759977
[patent_app_country] => US
[patent_app_date] => 2021-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19405
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 1409
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17759977
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/759977 | SUBSTITUTED FUSED IMIDAZOLE DERIVATIVES AND METHODS OF TREATING REFRACTIVE OCULAR DISORDERS | Jan 31, 2021 | Pending |
Array
(
[id] => 19519813
[patent_doc_number] => 12121511
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-10-22
[patent_title] => GLP-1R modulating compounds
[patent_app_type] => utility
[patent_app_number] => 17/159485
[patent_app_country] => US
[patent_app_date] => 2021-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 52400
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 1365
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17159485
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/159485 | GLP-1R modulating compounds | Jan 26, 2021 | Issued |
Array
(
[id] => 18666243
[patent_doc_number] => 11773121
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-10-03
[patent_title] => Antiviral compounds
[patent_app_type] => utility
[patent_app_number] => 17/157733
[patent_app_country] => US
[patent_app_date] => 2021-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 8922
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17157733
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/157733 | Antiviral compounds | Jan 24, 2021 | Issued |
Array
(
[id] => 18285801
[patent_doc_number] => 20230101273
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-30
[patent_title] => MESOIONIC INSECTICIDES
[patent_app_type] => utility
[patent_app_number] => 17/794971
[patent_app_country] => US
[patent_app_date] => 2021-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24174
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 169
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17794971
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/794971 | MESOIONIC INSECTICIDES | Jan 22, 2021 | Abandoned |
Array
(
[id] => 20730176
[patent_doc_number] => 12637423
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-05-26
[patent_title] => Aziridinyl functional compound
[patent_app_type] => utility
[patent_app_number] => 17/792005
[patent_app_country] => US
[patent_app_date] => 2021-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11390
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 397
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17792005
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/792005 | Aziridinyl functional compound | Jan 20, 2021 | Issued |
Array
(
[id] => 17141600
[patent_doc_number] => 20210309612
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-07
[patent_title] => FLUORINATED 2-AMINO-4-(SUBSTITUTED AMINO)PHENYL CARBAMATE DERIVATIVES
[patent_app_type] => utility
[patent_app_number] => 17/145453
[patent_app_country] => US
[patent_app_date] => 2021-01-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38065
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 371
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17145453
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/145453 | Fluorinated 2-amino-4-(substituted amino)phenyl carbamate derivatives | Jan 10, 2021 | Issued |